A real-world analysis of anamorelin in patients with advanced cancer; A Multicenter, Retrospective Cohort Study
Not Applicable
- Conditions
- cancer cachexia
- Registration Number
- JPRN-UMIN000051550
- Lead Sponsor
- Hokkaido Gastrointestinal Cancer Study Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 176
Inclusion Criteria
Not provided
Exclusion Criteria
1)Participation in the clinical trial is determined as unsuitable.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in FAACT appetite-related scores before and after starting anamorelin hydrochloride
- Secondary Outcome Measures
Name Time Method 1)Change in body weight (kg) before and after starting anamorelin hydrochloride 2)Change in ECOG PS after anamorelin hydrochloride initiation 3)Frequency of anamorelin-related adverse events 4)Change in FAACT appetite-related score after anamorelin hydrochloride initiation by patient's background 5)Weight change after anamorelin hydrochloride initiation by patient's backgrounds 6)Change in ECOG PS after starting anamorelin hydrochloride by patient's backgrounds 7)Frequency of adverse events attributable to anamorelin hydrochloride by patient's backgrounds